Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix AD Kandasamy, AK Chow, MAM Ali, R Schulz Cardiovascular research 85 (3), 413-423, 2010 | 474 | 2010 |
Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus: A glance DK Arulmozhi, A Veeranjaneyulu, SL Bodhankar Indian Journal of Pharmacology 36 (4), 217-221, 2004 | 192 | 2004 |
Migraine: current concepts and emerging therapies DK Arulmozhi, A Veeranjaneyulu, SL Bodhankar Vascular pharmacology 43 (3), 176-187, 2005 | 163 | 2005 |
GLP-1 based therapy for type 2 diabetes DK Arulmozhi, B Portha European journal of pharmaceutical sciences 28 (1-2), 96-108, 2006 | 149 | 2006 |
Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases MM Castro, AD Kandasamy, N Youssef, R Schulz Pharmacological Research 64 (6), 551-560, 2011 | 111 | 2011 |
Preliminary mechanistic studies on the smooth muscle relaxant effect of hydroalcoholic extract of Curcuma caesia DK Arulmozhi, N Sridhar, A Veeranjaneyulu, SK Arora Journal of herbal pharmacotherapy 6 (3-4), 117-124, 2006 | 93 | 2006 |
Mechanisms of cytosolic targeting of matrix metalloproteinase‐2 MAM Ali, AK Chow, AD Kandasamy, X Fan, LJ West, BD Crawford, ... Journal of cellular physiology 227 (10), 3397-3404, 2012 | 85 | 2012 |
Effect of eugenol on animal models of nociception R Kurian, DK Arulmozhi, A Veeranjaneyulu, SL Bodhankar Indian Journal of Pharmacology 38 (5), 341-345, 2006 | 65 | 2006 |
Parkinson's disease: genetics and beyond NN Inamdar, DK Arulmozhi, A Tandon, SL Bodhankar Current neuropharmacology 5 (2), 99-113, 2007 | 54 | 2007 |
Antipsychotic induced metabolic abnormalities: an interaction study with various PPAR modulators in mice DK Arulmozhi, DS Dwyer, SL Bodhankar Life sciences 79 (19), 1865-1872, 2006 | 54 | 2006 |
Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice AD Kandasamy, MM Sung, JJ Boisvenue, AJ Barr, JRB Dyck Nutrition & diabetes 2 (9), e45-e45, 2012 | 53 | 2012 |
Glycogen synthase kinase-3β is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts AD Kandasamy, R Schulz Cardiovascular research 83 (4), 698-706, 2009 | 53 | 2009 |
Inhibition of matrix metalloproteinase-2 by PARP inhibitors AC Nicolescu, A Holt, AD Kandasamy, P Pacher, R Schulz Biochemical and Biophysical Research Communications 387 (4), 646-650, 2009 | 48 | 2009 |
Metabolic effects of various antidiabetic and hypolipidaemic agents on a high‐fat diet and multiple low‐dose streptozocin (MLDS) mouse model of diabetes DK Arulmozhi, R Kurian, SL Bodhankar, A Veeranjaneyulu Journal of Pharmacy and Pharmacology 60 (9), 1167-1173, 2008 | 46 | 2008 |
Pharmacological studies of the aqueous extract of Sapindus trifoliatus on central nervous system: possible antimigraine mechanisms DK Arulmozhi, A Veeranjaneyulu, SL Bodhankar, SK Arora Journal of ethnopharmacology 97 (3), 491-496, 2005 | 41 | 2005 |
Antidiabetic and Antihyperlipidemic Effects of Myristica fragrans. in Animal Models DK Arulmozhi, R Kurian, A Veeranjaneyulu, SL Bodhankar Pharmaceutical Biology 45 (1), 64-68, 2007 | 39 | 2007 |
Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing … CJ Schulze, MM Castro, AD Kandasamy, J Cena, C Bryden, SH Wang, ... Critical care medicine 41 (11), 2512-2520, 2013 | 38 | 2013 |
Hydrogen peroxide-induced necrotic cell death in cardiomyocytes is independent of matrix metalloproteinase-2 MAM Ali, AD Kandasamy, X Fan, R Schulz Toxicology in Vitro 27 (6), 1686-1692, 2013 | 37 | 2013 |
Pharmacological investigations of Sapindus trifoliatus in various in vitro and in vivo models of inflammation DK Arulmozhi, A Veeranjaneyulu, SL Bodhankar, SK Arora Indian Journal of Pharmacology 37 (2), 96-102, 2005 | 37 | 2005 |
In vitro pharmacological investigations of Sapindus trifoliatus in various migraine targets DK Arulmozhi, N Sridhar, SL Bodhankar, A Veeranjaneyulu, SK Arora Journal of ethnopharmacology 95 (2-3), 239-245, 2004 | 33 | 2004 |